These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26289904)

  • 1. Lowering cholesterol in chronic kidney disease: is it safe and effective?
    Wong MG; Wanner C; Knight J; Perkovic V
    Eur Heart J; 2015 Nov; 36(43):2988-95. PubMed ID: 26289904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin use in patients with diabetes and kidney disease: the Japanese experience.
    Koya D; Campese VM
    J Atheroscler Thromb; 2013; 20(5):407-24. PubMed ID: 23518468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LDL-cholesterol lowering and renal outcomes.
    Waters DD
    Curr Opin Lipidol; 2015 Jun; 26(3):195-9. PubMed ID: 25887677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins in chronic kidney disease: cardiovascular risk and kidney function.
    Deedwania PC
    Postgrad Med; 2014 Jan; 126(1):29-36. PubMed ID: 24393749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ezetimibe as a potential treatment for dyslipidemia associated with chronic renal failure and renal transplant.
    Ahmed MH; Khalil AA
    Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1021-9. PubMed ID: 21060168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?
    Athyros VG; Katsiki N; Karagiannis A; Mikhailidis DP
    Expert Opin Pharmacother; 2015; 16(10):1449-61. PubMed ID: 26037614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?
    Fabbri G; Maggioni AP
    Adv Ther; 2009 May; 26(5):469-87. PubMed ID: 19444394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge.
    Rysz J; Gluba-Brzózka A; Banach M; Więcek A
    Int Urol Nephrol; 2015 May; 47(5):805-13. PubMed ID: 25758011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin therapy in patients with chronic kidney disease: to use or not to use.
    Steinmetz OM; Panzer U; Stahl RA; Wenzel UO
    Eur J Clin Invest; 2006 Aug; 36(8):519-27. PubMed ID: 16893373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis.
    Palmer SC; Craig JC; Navaneethan SD; Tonelli M; Pellegrini F; Strippoli GF
    Ann Intern Med; 2012 Aug; 157(4):263-75. PubMed ID: 22910937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG-CoA reductase inhibitors in chronic kidney disease.
    Olyaei A; Steffl JL; MacLaughlan J; Trabolsi M; Quadri SP; Abbasi I; Lerma E
    Am J Cardiovasc Drugs; 2013 Dec; 13(6):385-98. PubMed ID: 23975627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of statins on renal function.
    Agarwal R
    Mayo Clin Proc; 2007 Nov; 82(11):1381-90. PubMed ID: 17976359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins in chronic kidney disease and kidney transplantation.
    Kassimatis TI; Goldsmith DJ
    Pharmacol Res; 2014 Oct; 88():62-73. PubMed ID: 24995940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Cardiovascular Risk in Young Patients with CKD and the Role of Lipid-Lowering Therapy.
    Kratky V; Valerianova A; Hruskova Z; Tesar V; Malik J
    Curr Atheroscler Rep; 2024 Apr; 26(4):103-109. PubMed ID: 38289577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of statins in chronic kidney disease.
    Kalaitzidis RG; Elisaf MS
    Am J Nephrol; 2011; 34(3):195-202. PubMed ID: 21791915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins in patients with chronic kidney disease: why, who and when?
    Gluba A; Rysz J; Banach M
    Expert Opin Pharmacother; 2010 Nov; 11(16):2665-74. PubMed ID: 20977401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic kidney disease and dyslipidaemia].
    Pascual V; Serrano A; Pedro-Botet J; Ascaso J; Barrios V; Millán J; Pintó X; Cases A
    Clin Investig Arterioscler; 2017; 29(1):22-35. PubMed ID: 27863896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing dyslipidemia in chronic kidney disease.
    Harper CR; Jacobson TA
    J Am Coll Cardiol; 2008 Jun; 51(25):2375-84. PubMed ID: 18565393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis.
    Hou W; Lv J; Perkovic V; Yang L; Zhao N; Jardine MJ; Cass A; Zhang H; Wang H
    Eur Heart J; 2013 Jun; 34(24):1807-17. PubMed ID: 23470492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.